Get Started for Free Contexxia identifies hard-to-find pieces of information in SEC filings. No more highlighters, no more redlining, no more poring over huge documents.

During the nine months ended September 30, 2018, the Company received $16,000 from non-controlling interests representing 40% interests in various subsidiaries. The Company returned $100,500 to the non-controlling interests representing return of capital and distribution of earnings of the subsidiaries.


During the nine months ended September 30, 2019, the Company advanced Global Medical Equipment LLC $10,000. The advance is interest free and due upon demand.


The XBRL related information in Exhibits 101 to this Quarterly Report on Form 10-Q shall not be deemed “filed” or a part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act of 1933, as amended, and is not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of those sections.